Progress in Clinical Diagnosis and Therapy in Ophthalmology
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 16 March 2026 | Viewed by 323
Special Issue Editor
Interests: keratoconus; deep anterior lamellar keratoplasty; penetrative keratoplasty; ophthalmology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Ophthalmology is undergoing a transformative era marked by significant advancements in diagnostic precision and therapeutic innovation. The integration of high-resolution imaging technologies, artificial intelligence, and molecular diagnostics is reshaping how eye diseases are detected, monitored, and treated. Genetic discoveries have particularly deepened our understanding of inherited retinal disorders, glaucoma, and corneal dystrophies, paving the way for targeted therapies and gene-based interventions. At the same time, innovations in pharmacology, minimally invasive surgery, and tissue engineering are enhancing outcomes across a broad spectrum of ocular conditions. This Special Issue, "Progress in Clinical Diagnosis and Therapy in Ophthalmology", aims to present the latest developments in these rapidly evolving areas. Submissions are encouraged that explore breakthroughs in imaging, AI-assisted diagnostics, gene therapy, regenerative medicine, and other personalized approaches that promise to define the future of eye care. Interdisciplinary studies and translational research with clinical relevance are particularly welcome.
Prof. Dr. Edward Wylegala
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ophthalmic imaging
- artificial intelligence in ophthalmology
- retinal diseases
- corneal transplantation
- glaucoma diagnostics
- ocular therapeutics
- personalized medicine
- ocular genetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
